Hjem › Graft-versus-host-sygdom › Missouri
Graft-versus-host-sygdom kliniske forsøg i Missouri
4 studier for Graft-versus-host-sygdom søger deltagere på steder i Missouri.
Byer i Missouri
Officiel studietekst (engelsk)
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 2 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Washington University, St Louis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT06615050Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- Washington University School of Medicine, St Louis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. apr. 2026 · NCT06008808A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Washington University School of Medicine - Siteman Cancer Center, St Louis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.